Healthcare provider profile · identity verified

Michael W. Meredith, M.D.

Internal Medicine · DURHAM, NC · NPI 1588713507

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	671	195
Atorvastatin Calcium	Atorvastatin Calcium	660	184
Amlodipine Besylate	Amlodipine Besylate	456	130
Hydrochlorothiazide	Hydrochlorothiazide	330	105
Losartan Potassium	Losartan Potassium	328	97
Levothyroxine Sodium	Levothyroxine Sodium	259	67
Lisinopril	Lisinopril	250	71
Gabapentin	Gabapentin	207	66
Tamsulosin Hcl	Tamsulosin Hcl	203	60
Omeprazole	Omeprazole	194	61
Eliquis	Apixaban	193	42
Metformin Hcl	Metformin Hcl	181	49
Carvedilol	Carvedilol	162	45
Metoprolol Succinate	Metoprolol Succinate	160	49
Pantoprazole Sodium	Pantoprazole Sodium	141	39
Simvastatin	Simvastatin	141	40
Allopurinol	Allopurinol	138	34
Jardiance	Empagliflozin	131	34
Metformin Hcl Er	Metformin Hcl	127	38
Ramipril	Ramipril	120	33
Spironolactone	Spironolactone	118	35
Fluticasone Propionate	Fluticasone Propionate	117	58
Trazodone Hcl	Trazodone Hcl	113	30
Finasteride	Finasteride	107	30
Duloxetine Hcl	Duloxetine Hcl	104	24
Potassium Chloride	Potassium Chloride	104	33
Benazepril Hcl	Benazepril Hcl	101	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	89	24
Ezetimibe	Ezetimibe	85	28
Ozempic	Semaglutide	82	20
Sertraline Hcl	Sertraline Hcl	74	23
Escitalopram Oxalate	Escitalopram Oxalate	69	23
Mounjaro	Tirzepatide	66	suppressed
Alendronate Sodium	Alendronate Sodium	62	20
Montelukast Sodium	Montelukast Sodium	61	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	16
Albuterol Sulfate Hfa	Albuterol Sulfate	56	29
Tramadol Hcl	Tramadol Hcl	56	20
Fluoxetine Hcl	Fluoxetine Hcl	55	17
Bupropion Xl	Bupropion Hcl	54	14
Celecoxib	Celecoxib	54	17
Glimepiride	Glimepiride	54	15
Prednisone	Prednisone	52	21
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	52	16
Hydralazine Hcl	Hydralazine Hcl	49	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	suppressed
Pravastatin Sodium	Pravastatin Sodium	49	17
Alprazolam	Alprazolam	46	11
Oxycodone Hcl	Oxycodone Hcl	45	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	44	13
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Chlorthalidone	Chlorthalidone	41	12
Xarelto	Rivaroxaban	39	suppressed
Irbesartan	Irbesartan	37	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	36	12
Synthroid	Levothyroxine Sodium	36	12
Glipizide Er	Glipizide	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	12
Ipratropium Bromide	Ipratropium Bromide	34	13
Triamcinolone Acetonide	Triamcinolone Acetonide	34	19
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Furosemide	Furosemide	30	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Atenolol	Atenolol	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Famotidine	Famotidine	27	suppressed
Febuxostat	Febuxostat	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Temazepam	Temazepam	25	suppressed
Valsartan	Valsartan	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Lovastatin	Lovastatin	23	suppressed
Mometasone Furoate	Mometasone Furoate	23	suppressed
Torsemide	Torsemide	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Nystatin	Nystatin	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Nitroglycerin	Nitroglycerin	21	15
Diazepam	Diazepam	20	suppressed
Dutasteride	Dutasteride	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	11
Eplerenone	Eplerenone	18	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Colchicine	Colchicine	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	14	suppressed
Brilinta	Ticagrelor	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Glipizide	Glipizide	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Repatha Syringe	Evolocumab	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Azithromycin	Azithromycin	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error